A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 156.94
GOOG 908.32
MSFT 71.99
BAC 23.56
FB 166.24

Recently Added

ATHM 63.78
ANDV 92.98
APEN 4.43
CALA 14.02
ISIG 1.00

Gaining Speed

ANDV 92.98
APEN 4.43
ATHM 63.78
PSA 196.96
OHI 31.47

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!